Que Zenglong, Wu Mingsong, Lai Shujie, Wang Lei, Mu Zhiyong, Yang Jinhui, Xiong Wei, Hu Hong, Liu Aimin, An Xuan, Yu Haodong, Cao Qin, Zhang Yanmei, Luo Wenwen, Wang Jun, Chen Dongfeng, Liu Fuquan, Zhang Dazhi, Wen Liangzhi
Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Department of Infectious Diseases, The 960 Hospital of PLA, Jinan, China.
Front Med (Lausanne). 2024 Sep 30;11:1456758. doi: 10.3389/fmed.2024.1456758. eCollection 2024.
There is no established scoring model focused on viral hepatitis patients to predict the prognosis after transjugular intrahepatic portosystemic shunt (TIPS). We aimed to develop and validate a novel model based on the largest cohort for better prediction of both short-term (1 year) and long-term (3 years) postoperative prognoses after TIPS in viral hepatitis cirrhosis-related portal hypertension patients.
A total of 925 viral hepatitis cirrhosis-related portal hypertension patients who underwent TIPS from nine hospitals were divided into the training and external validation cohorts. A novel Viral-associated Index of Post-TIPS score (VIPs) model was developed after performing Cox regression analysis. The VIPs model was compared to five previous models, namely, Child-Pugh, MELD, ALBI, CCG, and FIPS. Furthermore, X-tile software was used to stratify patients into low-, medium-, and high-risk groups.
The VIPs model included age, ascites, albumin, prothrombin time, total bilirubin, and sodium for post-TIPS prognosis prediction. The model demonstrated satisfying predictive efficiency in both discrimination and calibration, with an area under the curve of 0.781/0.774 (1 year/3 years) in the training cohort and 0.771/0.775 (1 year/3 years) in the external validation cohort, respectively.
We first developed and externally validated a novel VIPs model for better prediction of both short-term and long-term postoperative prognoses after TIPS in Chinese patients with viral hepatitis cirrhosis-related portal hypertension.
目前尚无专门针对病毒性肝炎患者预测经颈静脉肝内门体分流术(TIPS)后预后的评分模型。我们旨在基于最大队列开发并验证一种新型模型,以更好地预测病毒性肝炎肝硬化相关门静脉高压患者TIPS术后的短期(1年)和长期(3年)预后。
将来自9家医院的925例接受TIPS的病毒性肝炎肝硬化相关门静脉高压患者分为训练队列和外部验证队列。在进行Cox回归分析后开发了一种新型的TIPS术后病毒相关指数评分(VIPs)模型。将VIPs模型与之前的5种模型进行比较,即Child-Pugh、MELD、ALBI、CCG和FIPS。此外,使用X-tile软件将患者分为低、中、高风险组。
VIPs模型纳入年龄、腹水、白蛋白、凝血酶原时间、总胆红素和钠用于预测TIPS术后预后。该模型在区分度和校准方面均显示出令人满意的预测效率,训练队列中曲线下面积分别为0.781/0.774(1年/3年),外部验证队列中为0.771/0.775(1年/3年)。
我们首次开发并在外部验证了一种新型VIPs模型,以更好地预测中国病毒性肝炎肝硬化相关门静脉高压患者TIPS术后的短期和长期预后。